MENU
  • Home
  • About Us
    • Our Core Values
    • Company Information
    • Founder’s Message
  • People
    • CEO: Hiro Kimura, Ph.D., R.Ph.
    • Advisors
      • Tom Curran, Ph.D., FRS
      • Joe Bolen, Ph.D.
      • Guanghui Hu, Ph.D.
      • Karuppiah Kannan, Ph.D.
  • Business
    • BNCT Project 1102
    • NewXus Fund
  • News & Article
  • Contact Us
  • JP
Bloom X³
Empowering Life Science for Blooming Life
  • Home
  • About Us
    • Our Core Values
    • Company Information
    • Founder’s Message
  • People
    • CEO: Hiro Kimura, Ph.D., R.Ph.
    • Advisors
      • Tom Curran, Ph.D., FRS
      • Joe Bolen, Ph.D.
      • Guanghui Hu, Ph.D.
      • Karuppiah Kannan, Ph.D.
  • Business
    • BNCT Project 1102
    • NewXus Fund
  • News & Article
  • Contact Us
  • JP
  • Home
  • About Us
  • People
  • Business
  • News & Article
  • Contact Us
  • JP
  1. Home
  2. 2026年
  3. February

February 2026– date –

  • News

    Bloom X³ News:Congratulations to Dr. Joe Bolen and Orna Therapeutics on the Acquisition by Eli Lilly

    Bloom X³ Inc. extends its sincere congratulations to Dr. Joe Bolen, Advisor to Bloom X³ and Chief Executive Officer of Orna Therapeutics, and to the entire Orna team on the announced acquisition by Eli Lilly and Company. According to the...
    February 25, 2026
  • Activity

    Meeting with Nobel Laureate Prof. Shinya Yamanaka

    Bloom X³ Inc. (Founder & CEO: Hiromichi Kimura) recently met with Nobel Laureate Prof. Shinya Yamanaka at Gladstone Institutes (a UCSF-affiliated research institute) in California, USA. Prof. Yamanaka is Director Emeritus of the Cent...
    February 2, 2026
  • Activity

    Invited Talk at ASDRP: “Research vs. Business—How to Navigate Career Inflection Points”

    Our CEO (Hiro Kimura, Ph.D., R.Ph.) was invited to ASDRP’s Guest Speaker Series and delivered a lecture for high school students in the San Francisco Bay Area.*ASDRP (Aspiring Scholars Directed Research Program): a nonprofit, private res...
    February 1, 2026
1

最近の投稿

  • Bloom X³ Founder & CEO Hiro Kimura Participated in Coolwater Capital’s Investor Summit and Strengthened US Engagement in San Francisco
  • Research Collaboration with Kansai BNCT Medical Center, Osaka Medical and Pharmaceutical University, Enters Phase 2 — The 1102 Program Toward Aging, Rejuvenation, and Regenerative Medicine
  • Bloom X³ News:Congratulations to Dr. Joe Bolen and Orna Therapeutics on the Acquisition by Eli Lilly
  • Meeting with Nobel Laureate Prof. Shinya Yamanaka
  • Invited Talk at ASDRP: “Research vs. Business—How to Navigate Career Inflection Points”

最近のコメント

No comments to show.

アーカイブ

  • May 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • September 2025
  • August 2025
  • June 2025
  • May 2025

カテゴリー

  • Activity
  • Article
  • News
  • Home
  • Privacy Policy
  • Terms of Use
  • Contact Us

© Bloom X³

  • Menu
  • Home
  • Privacy Policy
  • Terms of Use
  • Contact Us